Stockscreener 앱 받기
27.62
5.82%
1.52
시간 외 거래:
27.62
전일 마감가:
$26.10
열려 있는:
$26.51
하루 거래량:
182.94K
Relative Volume:
0.58
시가총액:
$181.16M
수익:
-
순이익/손실:
$-74.14M
주가수익비율:
-2.4249
EPS:
-11.39
순현금흐름:
$-65.70M
1주 성능:
+12.78%
1개월 성능:
-0.29%
6개월 성능:
+40.85%
1년 성능:
+118.34%
1일 변동 폭
$25.58
$28.80
1주일 범위
$22.73
$28.80
52주 변동 폭
$9.85
$92.00
인스틸 바이오 Stock (TIL) Company Profile
명칭
Instil Bio Inc
전화
(972) 499-3350
주소
3963 MAPLE AVENUE, DALLAS
TIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
27.62 | 160.65M | 0 | -74.14M | -65.70M | -11.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
인스틸 바이오 Stock (TIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Perform |
| 2024-04-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-11-01 | 다운그레이드 | Truist | Buy → Hold |
| 2021-08-13 | 개시 | Robert W. Baird | Outperform |
| 2021-04-13 | 개시 | Cowen | Outperform |
| 2021-04-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-04-13 | 개시 | Truist | Buy |
모두보기
인스틸 바이오 주식(TIL)의 최신 뉴스
What drives Instil Bio Inc. stock priceUnprecedented market success - Autocar Professional
Instil Bio Inc. Stock Analysis and ForecastExponential return rates - PrintWeekIndia
Will Instil Bio Inc. stock benefit from interest rate changesSolid Return Trade Selections - Newser
(TIL) Proactive Strategies - news.stocktradersdaily.com
Is Instil Bio Inc. a good long term investmentFree Advanced Stock Screener Access - jammulinksnews.com
What analysts say about Instil Bio Inc. stockFree Stock Selection - jammulinksnews.com
When is the best time to buy Instil Bio Inc. stockEntry Level Low Risk Picks - Newser
Why Instil Bio Inc. stock attracts strong analyst attentionProtected Capital Trading Plan - Newser
What makes Instil Bio Inc. stock price move sharplyFree Consultation - Newser
How Instil Bio Inc. stock performs during market volatilityTop Growth Low Risk Stocks - Newser
Instil Bio stock jumps after FDA clearance of IND application - Investing.com
Instil Bio stock jumps after FDA clearance of IND application By Investing.com - Investing.com UK
Instil Bio, Inc. Announces U.S. F.D.A. Clearance of Investigational New Drug Application for AXN-2510 - MarketScreener
FDA clears Instil Bio’s IND for AXN-2510 cancer therapy - Investing.com
Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha
Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet - MSN
Instil Bio (TIL) Enhances Axion Bio Board with New Appointment | - GuruFocus
Instil Bio Names John Maraganore, Ph.D., to Board Role - GlobeNewswire
Instil Bio Names John Maraganore, Ph.D., To Board - citybiz
Instil Bio, Inc. Announces the Addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Its Wholly-Owned Subsidiary - MarketScreener
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program - Yahoo Finance
(TIL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Instil Bio Appoints ‘Seasoned’ Biopharma Exec as Chief Medical Officer - Dallas Innovates
H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news By Investing.com - Investing.com South Africa
Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwrig - GuruFocus
H.C. Wainwright reiterates Instil Bio stock Buy rating amid partnership news - Investing.com Canada
Instil Bio (TIL) Receives Reiterated Buy Rating from HC Wainwright & Co. | TIL Stock News - GuruFocus
Are You Looking for a Top Momentum Pick? Why Instil Bio, Inc. (TIL) is a Great Choice - Yahoo Finance
Instil Bio appoints new Chief Medical Officer By Investing.com - Investing.com South Africa
Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Secu - GuruFocus
Instil Bio (TIL) Rating Reiterated as Market Perform by JMP Securities | TIL Stock News - GuruFocus
인스틸 바이오 (TIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.87%
0.17%
자본화:
|
볼륨(24시간):